Literature DB >> 13480570

Functional obstruction of the left ventricle; acquired aortic subvalvar stenosis.

R BROCK.   

Abstract

Entities:  

Keywords:  AORTIC VALVE/stenosis; CARDIAC ENLARGEMENT/complications

Mesh:

Year:  1957        PMID: 13480570

Source DB:  PubMed          Journal:  Guys Hosp Rep        ISSN: 0017-5889


× No keyword cloud information.
  71 in total

Review 1.  Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy.

Authors:  E D Wigle
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

2.  THE SURGICAL MANAGEMENT OF OBSTRUCTIVE CARDIOMYOPATHY.

Authors:  W P CLELAND
Journal:  Proc R Soc Med       Date:  1964-06

3.  OBSTRUCTIVE CARDIOMYOPATHY: CLINICAL FEATURES.

Authors:  J F GOODWIN
Journal:  Proc R Soc Med       Date:  1964-06

4.  HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY.

Authors:  J COHEN; H EFFAT; J F GOODWIN; C M OAKLEY; R E STEINER
Journal:  Br Heart J       Date:  1964-01

5.  PRESSURE-FLOW STUDIES IN HYPERTROPHIC SUBAORTIC STENOSIS.

Authors:  R R HERNANDEZ; J C GREENFIELD; B W MCCALL
Journal:  J Clin Invest       Date:  1964-03       Impact factor: 14.808

6.  CARDIAC FUNCTION IN PRIMARY MYOCARDIAL DISORDERS II.

Authors:  J F GOODWIN
Journal:  Br Med J       Date:  1964-06-20

7.  HAEMODYNAMIC EFFECTS OF CHANGES IN BLOOD VOLUME IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY.

Authors:  P M SHAH; R AMARASINGHAM; C M OAKLEY
Journal:  Br Heart J       Date:  1965-01

8.  THE CONTOUR OF THE SUBVALVAR PRESSURE CURVE IN SUBAORTIC STENOSIS.

Authors:  S STAVROPOULOS; H DAVIES
Journal:  Br Heart J       Date:  1965-07

9.  SURGICAL TREATMENT AND POST-OPERATIVE HAEMODYNAMIC STUDIES IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY.

Authors:  H H BENTALL; W P CLELAND; C M OAKLEY; P M SHAH; R E STEINER; J F GOODWIN
Journal:  Br Heart J       Date:  1965-07

10.  Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy.

Authors:  A G MORROW; E C BROCKENBROUGH
Journal:  Ann Surg       Date:  1961-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.